Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | leukotriene A 4 hydrolase | 0.0456 | 0.2274 | 1 |
Echinococcus granulosus | Solute carrier family 22 5 | 0.1023 | 0.5426 | 1 |
Mycobacterium tuberculosis | Probable zinc metalloprotease Zmp1 | 0.0094 | 0.026 | 0.5 |
Schistosoma mansoni | leukotriene A4 hydrolase (M01 family) | 0.0456 | 0.2274 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.0132 | 0.0009 |
Loa Loa (eye worm) | leukotriene A4 hydrolase | 0.0456 | 0.2274 | 0.2178 |
Toxoplasma gondii | peptidase family M13 protein | 0.0094 | 0.026 | 0.5 |
Loa Loa (eye worm) | angiotensin-converting enzyme family protein | 0.1845 | 1 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.0132 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.0132 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.026 | 0.0139 |
Schistosoma mansoni | family M13 unassigned peptidase (M13 family) | 0.0094 | 0.026 | 0.1144 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.026 | 0.0139 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.0132 | 0.0009 |
Loa Loa (eye worm) | hypothetical protein | 0.0094 | 0.026 | 0.0139 |
Mycobacterium leprae | probable zinc metalloprotease | 0.0094 | 0.026 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.0132 | 0.0009 |
Echinococcus granulosus | leukotriene A 4 hydrolase | 0.0456 | 0.2274 | 0.3899 |
Loa Loa (eye worm) | hypothetical protein | 0.0071 | 0.0132 | 0.0009 |
Mycobacterium ulcerans | zinc metalloprotease | 0.0094 | 0.026 | 0.5 |
Brugia malayi | hypothetical protein | 0.021 | 0.0903 | 0.0659 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Activity (functional) | = 0.68 | DNA topoisomerase I cleavage at 1 uM relative to SN38 | ChEMBL. | 12873503 |
Cells arrested (functional) | = 78 % | Percentage of L1210 leukemia cells arrested in G2+ M phase of cell cycle by 5 uM concentration | ChEMBL. | 12873503 |
Cells arrested (functional) | = 78 % | Percentage of L1210 leukemia cells arrested in G2+ M phase of cell cycle by 5 uM concentration | ChEMBL. | 12873503 |
IC50 (functional) | = 1 uM | Inhibitory concentration of the compound against L1210 leukemia cell proliferation | ChEMBL. | 12873503 |
IC50 (functional) | = 1 uM | Inhibitory concentration of the compound against L1210 leukemia cell proliferation | ChEMBL. | 12873503 |
IC50 (functional) | = 1 uM | Cytotoxicity against mouse L1210 cells | ChEMBL. | 23578545 |
Inhibition (binding) | = 0.68 % | Inhibition of topoisomerase 1 (unknown origin)-mediated DNA cleavage at 1 uM relative to SN-38 | ChEMBL. | 23578545 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Mus musculus | ChEMBL23 | 12873503 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
2 literature references were collected for this gene.